Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO

NCT04137679 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Esophageal Cancer

Interventions

RADIATION: Definitive Radiochemotherapy
PROCEDURE: Neoadjuvant Radiochemotherapy followed by surgery

Sponsor

Tianjin Medical University Cancer Institute and Hospital